Accuray | ARAY - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Abbott USD 3.6B 330M 2026-06
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.56M 1.99M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Inogen USD 43.77M 510K 2024-06
Mesa Laboratories USD 27.31M 380K 2024-09
Orthofix International USD 130.35M 11.31M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Trinity Biotech USD 5.78M 405K 2025-12